Chartered Financial Analyst, Osman Ghani, Provides Price Target for Oxygen Biotherapeutics, Inc.

NEW YORK, Jan. 13, 2014 /PRNewswire/ -- Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) has been chosen by CFA, Osman Ghani to feature in a extensive research report that covers key features of the bio-technology market, Porter's five forces, US FDA approval process, new acquisition and demand, capital structure, and value of the company. The comprehensive CFA research report on OXBT with a price target can be viewed in its entirety by using this link: http://bit.ly/CFAResearchReportOXBT copy and paste to browser may be required

EDITOR NOTES:

1. Information in this release is fact checked and produced on a best efforts basis and reviewed by Osman Ghani, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

2. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

3. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].

4.  For any urgent concerns or inquiries, please contact us at [email protected].

5. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared by Small Cap Specialists, LLC and authored by Osman Ghani, CFA. An outsourced research services provider represented by Osman Ghani, CFA, has only reviewed the information provided by Small Cap Specialists, LLC in this article or report. Small Cap Specialists, LLC is not entitled to veto, interfere or alter the articles, documents or report once reviewed by the outsourced research provider represented by Osman Ghani, CFA.

NOT FINANCIAL ADVICE

Small Cap Specialists, LLC makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Small Cap Specialists, LLC is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Small Cap Specialists, LLC whatsoever for any direct, indirect or consequential loss arising from the use of this document. Small Cap Specialists, LLC expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Small Cap Specialists, LLC does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Small Cap Specialists, LLC

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED